A. Bergami

507 total citations
8 papers, 424 citations indexed

About

A. Bergami is a scholar working on Molecular Biology, Immunology and Infectious Diseases. According to data from OpenAlex, A. Bergami has authored 8 papers receiving a total of 424 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Molecular Biology, 3 papers in Immunology and 2 papers in Infectious Diseases. Recurrent topics in A. Bergami's work include Cell death mechanisms and regulation (2 papers), Herpesvirus Infections and Treatments (2 papers) and Peripheral Neuropathies and Disorders (2 papers). A. Bergami is often cited by papers focused on Cell death mechanisms and regulation (2 papers), Herpesvirus Infections and Treatments (2 papers) and Peripheral Neuropathies and Disorders (2 papers). A. Bergami collaborates with scholars based in Italy, Switzerland and United States. A. Bergami's co-authors include Roberto Furlan, Gianvito Martino, Gıancarlo Comı, Pietro Luigi Poliani, Francesca Galbiati, Luciano Adorini, Gaetano Desina, Michael Su, Simona Smiroldo and Richard A. Flavell and has published in prestigious journals such as The Journal of Immunology, Journal of Neurology Neurosurgery & Psychiatry and Journal of Neuroimmunology.

In The Last Decade

A. Bergami

8 papers receiving 409 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
A. Bergami Italy	8	214	183	74	73	54	8	424
Steve Gendron Canada	9	169 0.8×	255 1.4×	67 0.9×	81 1.1×	121 2.2×	11	532
Ming Cao United States	12	175 0.8×	186 1.0×	60 0.8×	69 0.9×	131 2.4×	21	553
Rose M. Ko United States	8	146 0.7×	167 0.9×	137 1.9×	73 1.0×	41 0.8×	13	388
Sabine Desbois France	12	71 0.3×	372 2.0×	118 1.6×	83 1.1×	68 1.3×	14	524
Mikkel Carstensen Denmark	8	135 0.6×	148 0.8×	99 1.3×	81 1.1×	46 0.9×	12	366
Roberto Meza‐Romero United States	17	108 0.5×	464 2.5×	71 1.0×	154 2.1×	61 1.1×	37	665
Alexandra Treschow Sweden	9	133 0.6×	233 1.3×	42 0.6×	43 0.6×	139 2.6×	12	470
Timothy Weeden Slovakia	7	155 0.7×	101 0.6×	64 0.9×	13 0.2×	41 0.8×	8	336
Rebecca A. Sweet United States	11	132 0.6×	521 2.8×	100 1.4×	31 0.4×	64 1.2×	12	732
Keith A. Sikora United States	13	98 0.5×	216 1.2×	103 1.4×	73 1.0×	66 1.2×	22	478

Countries citing papers authored by A. Bergami

Since Specialization

Citations

This map shows the geographic impact of A. Bergami's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A. Bergami with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A. Bergami more than expected).

Fields of papers citing papers by A. Bergami

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by A. Bergami. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A. Bergami. The network helps show where A. Bergami may publish in the future.

Co-authorship network of co-authors of A. Bergami

This figure shows the co-authorship network connecting the top 25 collaborators of A. Bergami. A scholar is included among the top collaborators of A. Bergami based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with A. Bergami. A. Bergami is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

8 of 8 papers shown

1.

Khorooshi, Reza, Francesca Ruffini, Morten Løbner, et al.. (2012). Lentiviral-mediated administration of IL-25 in the CNS induces alternative activation of microglia. Gene Therapy. 20(5). 487–496. 20 indexed citations

2.

Ruffini, Francesca, A. Bergami, Elena Brambilla, et al.. (2009). Administration of a monomeric CCL2 variant to EAE mice inhibits inflammatory cell recruitment and protects from demyelination and axonal loss. Journal of Neuroimmunology. 209(1-2). 33–39. 21 indexed citations

3.

Furlan, Roberto, Massimo Filippi, A. Bergami, et al.. (1999). Peripheral levels of caspase-1 mRNA correlate with disease activity in patients with multiple sclerosis; a preliminary study. Journal of Neurology Neurosurgery & Psychiatry. 67(6). 785–788. 56 indexed citations

4.

Sipe, J.C., Massimo Filippi, Gianvito Martino, et al.. (1999). Method for intracellular magnetic labeling of human mononuclear cells using approved iron contrast agents. Magnetic Resonance Imaging. 17(10). 1521–1523. 59 indexed citations

5.

Furlan, Roberto, Gianvito Martino, Francesca Galbiati, et al.. (1999). Caspase-1 Regulates the Inflammatory Process Leading to Autoimmune Demyelination. The Journal of Immunology. 163(5). 2403–2409. 166 indexed citations

6.

Furlan, Roberto, Pietro Luigi Poliani, Francesca Galbiati, et al.. (1998). Central Nervous System Delivery of Interleukin 4 by a Nonreplicative Herpes Simplex Type 1 Viral Vector Ameliorates Autoimmune Demyelination. Human Gene Therapy. 9(17). 2605–2617. 68 indexed citations

7.

Furlan, Roberto, Pietro Luigi Poliani, Francesca Galbiati, et al.. (1998). Central Nervous System Delivery of Interleukin 4 by a Nonreplicative Herpes Simplex Type 1 Viral Vector Ameliorates Autoimmune Demyelination. Human Gene Therapy. 9(17). 2605–2617. 22 indexed citations

8.

Martino, Gianvito, Roberto Furlan, Francesca Galbiati, et al.. (1998). A gene therapy approach to treat demyelinating diseases using nonreplicative herpetic vectors engineered to produce cytokines. Multiple Sclerosis Journal. 4(3). 222–227. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact